Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.
Schreckenberger M, Hägele S, Siessmeier T, Buchholz HG, Armbrust-Henrich H, Rösch F, Gründer G, Bartenstein P, Vogt T. Schreckenberger M, et al. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1128-35. doi: 10.1007/s00259-004-1465-5. Epub 2004 Mar 23. Eur J Nucl Med Mol Imaging. 2004. PMID: 15042325 Clinical Trial.
Preoperative mapping of cortical motor function: prospective comparison of functional magnetic resonance imaging and [15O]-H2O-positron emission tomography in the same co-ordinate system.
Reinges MH, Krings T, Meyer PT, Schreckenberger M, Rohde V, Weidemann J, Sabri O, Mulders EJ, Buell U, Thron A, Gilsbach JM. Reinges MH, et al. Among authors: schreckenberger m. Nucl Med Commun. 2004 Oct;25(10):987-97. doi: 10.1097/00006231-200410000-00002. Nucl Med Commun. 2004. PMID: 15381866 Clinical Trial.
Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli.
Kienast T, Siessmeier T, Wrase J, Braus DF, Smolka MN, Buchholz HG, Rapp M, Schreckenberger M, Rösch F, Cumming P, Gruender G, Mann K, Bartenstein P, Heinz A. Kienast T, et al. Among authors: schreckenberger m. Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1147-58. doi: 10.1007/s00259-007-0683-z. Epub 2008 Jan 17. Eur J Nucl Med Mol Imaging. 2008. PMID: 18202844
[Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)].
Tatsch K, Buchert R, Bartenstein P, Barthel H, Boecker H, Brust P, Drzezga A, la Fougère C, Gründer G, Grünwald F, Krause BJ, Kuwert T, Langen KJ, Rominger A, Sabri O, Schreckenberger M, Meyer PT. Tatsch K, et al. Among authors: schreckenberger m. Nuklearmedizin. 2019 Feb;58(1):5-16. doi: 10.1055/a-0807-8137. Epub 2019 Feb 15. Nuklearmedizin. 2019. PMID: 30769368 German.
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Nestle U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme A, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Gkika E, Adebahr S, König J, Grosu AL; PET-Plan study group. Nestle U, et al. Lancet Oncol. 2020 Apr;21(4):581-592. doi: 10.1016/S1470-2045(20)30013-9. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171429 Clinical Trial.
191 results